Ignite Creation Date:
2024-05-05 @ 11:41 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01398189
Status:
UNKNOWN
Last Update Posted:
2013-11-21
First Post:
2011-07-19
Brief Title:
F-18 Altanserin PET Study of Patients Receiving Clozapine
Sponsor:
Seoul National University Bundang Hospital
Organization:
Seoul National University Bundang Hospital
Study Overview
Official Title:
Validation of Molecular Imaging Technologies for Early Clinical Trials
Status:
UNKNOWN
Status Verified Date:
2013-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
APC
Brief Summary:
To examine the feasibility of molecular imaging markers in clinical psychopharmacology
Detailed Description:
Clinical evaluation of patients with psychiatric disorders is mainly dependent on patients reports and clinicians observations In order to develop objective and quantifiable measures of psychopathology molecular imaging techniques will be used in patients receiving clozapine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None